| 
		              			 
		                			
									
									
																	
										
		 							
									
		                			
		            			 
		          			 | 
		 	  				
		            			
		            				
	
			    				
		                			 
	
		            			
		            			
		            				
		                				
	
	PageContent 
	
	
		
			 Responsiveness to microbe-associated molecular patterns in Brachypodium distachyon A. TAKAHASHI (1), Y. Kouzai (1), M. Kimura (1), M. Watanabe (1), H. Matsui (1), M. Yamamoto (1), Y. Ichinose (1), K. Toyoda (1), Y. Noutoshi (1) (1) Okayama University, Japan
  Brachypodium distachyon (purple false brome) is a grass plant of the Pooideae subfamily, which  includes economically important crops such as wheat, barley, rye and oats. Owing to its small  stature, short lifecycle, self-fertility and small diploid genome (272Mbp), Brachypodium can be an  experimental model plant for studies of monocotyledonous plants. A whole-genome sequence, a  database of full-length cDNA (FLcDNA) and collections of mutants and accessions are available.  Since various pathogens threatening world crop cultivation such as Fusarium graminearum and  Magnaporthe oryzae can infect to Brachypodium, it may also be a useful platform to investigate both  pathogen virulence and plant immune response at the molecular level. Here we analysed  responsiveness of Brachypodium to various microbe-associated molecular patterns (MAMPs) such  as chitin, lipopolysaccharide, peptidoglycan, flg22 peptide and elf18 peptide. Production of reactive  oxygen species (ROS) to various MAMPs was favorably measured using leaf discs and luminol but  not L-012. ROS productions were detected to all the tested MAMPs from 0.5 to 3 h. The intensity  peaks of ROS were around 2 h except for flg22 with 1 h. We then successfully identified 8 marker  genes for the monitoring of MAMP response based on the sequence similarity to chitin responsive  genes in rice. Their expressions in leaf discs were detected 6 h after the treatments of each MAMP.
  Abstract Number: 
				P17-621 Session Type: 
				Poster  
 
  |  
  
		 
	 
 
		                			
		            			 
		          			 | 
		        		
		        		
		          			| 
		 	    				 
	
		          			 |